← Back

Rentokil Initial: Disappointing EPS, But Revenue Growth And Margin Expansion Tell A Different Story

The company's financial performance for the year was mixed, with revenue growing 3.8% to $6.9 billion, slightly above analysts' estimates, and adjusted operating profit increasing by 5.4% to just over $1 billion. However, actual EPS came out at $0.03714, significantly lower than estimates of $0.09518. The group's adjusted operating profit margin was 15.5%, a 30 basis point increase year-on-year. The North America segment reported revenue growth of 3.2% to $4.3 billion, with an adjusted operating profit margin of 17.4%.

RTO.L

GBp 463.5

-1.63%

A-Score: 3.5/10

Publication date: March 5, 2026

Author: Analystock.ai

πŸ“‹ Highlights
  • North America Organic Growth Q4 organic growth reached 2.6% driven by new marketing, 150 local branches, and $25M cost savings.
  • Adjusted Operating Profit Growth 5.4% increase to $1.0B, with 17.4% margin in North America, nearing 2027 20% margin target.
  • Free Cash Flow Performance $615M generated (98% conversion), net debt reduced to $3.65B (down from $4B), debt/EBITDA at 2.6x.
  • Market Expansion Strategy 2026 plans include 30 regional/local brands and 220 small branches to boost local presence and organic leads.
  • Industry Growth Outlook Pest control market grows at 6.2% CAGR to 2027, while Hygiene & Wellbeing market projects 4% annual growth through 2030.

Revenue Growth Drivers

The company's revenue growth was driven by a combination of factors, including the successful rollout of its new marketing plan, investment in regional brands, and the opening of 150 small local branches. The International business also saw improving organic revenue growth of 3.4% in the second half. According to Andrew Ransom, "We're laser-focused on creating an undisputed powerhouse in pest control, with a proven operating model centered on being an employer of choice and customer service."

Margin Expansion And Cost Savings

The company's adjusted operating profit margin expansion was driven by cost efficiencies, with $25 million of in-year cost savings delivered through its efficiency program. The company is targeting a 20% plus margin by 2027 and is on track to meet this goal. As Paul Edgecliffe-Johnson mentioned, "We're expecting better control, visibility, and consistency across our branches than ever before."

Valuation Metrics

Using the current valuation metrics, the company's P/E Ratio is 66.17, indicating that the market is pricing in significant growth expectations. The EV/EBITDA ratio is 23.11, which is relatively high. However, the Dividend Yield is 1.6%, and the Free Cash Flow Yield is 4.05%, indicating that the company is generating significant cash flows. Analysts estimate next year's revenue growth at 4.2%, which may not be sufficient to justify the current valuation multiples.

Outlook

The company's guidance for 2026 is positive, with plans to expand its multi-brand strategy, increase its local presence, and continue to roll out its local network of branches. The company is also investing in new data and pricing capabilities, and its new approach to pay plans will simplify the process and reduce complexity.

Rentokil Initial's A-Score